2010
DOI: 10.1136/bjo.2010.183244
|View full text |Cite
|
Sign up to set email alerts
|

Topical 1% 5-fluorouracil in ocular surface squamous neoplasia: a long-term safety study

Abstract: Topical 5-FU, as a sole or combined therapy, must be considered a long-term safe and effective treatment for patients affected by OSSN.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

5
76
0
2

Year Published

2011
2011
2022
2022

Publication Types

Select...
5
4

Relationship

0
9

Authors

Journals

citations
Cited by 88 publications
(83 citation statements)
references
References 26 publications
5
76
0
2
Order By: Relevance
“…5FU iyi tolere edilir, geçici konjonktivit, yüzeyel keratit dışında komplikasyonu yoktur. 8,15,27 İnterferon Çeşitli immün hücrelerden salınan doğal glikoproteindir. Hedef hücre yüzeyine bağlanarak effektör proteinleri aktive eder.…”
Section: Tedaviunclassified
“…5FU iyi tolere edilir, geçici konjonktivit, yüzeyel keratit dışında komplikasyonu yoktur. 8,15,27 İnterferon Çeşitli immün hücrelerden salınan doğal glikoproteindir. Hedef hücre yüzeyine bağlanarak effektör proteinleri aktive eder.…”
Section: Tedaviunclassified
“…Adjunctive tumour clinical features, such as nodularity, mutifocality, prominent vascularisation (presence of macroscopically evident tumour vessels or conjunctival feeder vessels), and fornix involvement were also reported. 9 Tumour clinical aspect was documented by anterior segment photography. Scraping cytology specimens were obtained at baseline from all patients.…”
Section: Methodsmentioning
confidence: 99%
“…Topical chemotherapy mitomycin or flurouracil is used as adjuvant therapy in treating noninvasive surface dysplasia and neoplasia [5][6][7]. Local brachytherapy and topical interferons also have been used in treating OSSN as an adjuvant therapy [4,6,8]. In a study extensive disease topical chemotherapy alone has been tried in the treating the lesions [9].…”
Section: Introductionmentioning
confidence: 99%
“…The most common treatment for OSSN is generally excision with a 4mm safe margin along with cryo to edges of resected conjunctiva and base of the lesion [4]. Topical chemotherapy mitomycin or flurouracil is used as adjuvant therapy in treating noninvasive surface dysplasia and neoplasia [5][6][7].…”
Section: Introductionmentioning
confidence: 99%